RE:News from Friday"Martin Bott has established a significant leadership position in financial and business expertise with one of the world's leading pharmaceutical companies. His depth of knowledge in navigating the complexities in healthcare finance and operations on a global level will be invaluable to InMed," said Eric A. Adams, President & Chief Executive Officer. "We welcome Martin to our Board and look forward to his strategic counsel as we work towards achieving our many corporate objectives."
$IMLFF